Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Delayed Nasdaq  -  04:00 2022-10-06 pm EDT
125.15 USD   -0.37%
03:52aIndonesia in talks with African countries to export its homemade COVID shot
RE
03:21aIndonesia in talks with African countries to export its homemade COVID shot
RE
10/06Analysis-As China party congress looms, signals sought on easing COVID policy
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

SVB Securities Adjusts Moderna's Price Target to $74 from $77, Keeps Underperform Rating

08/04/2022 | 09:52am EDT


© MT Newswires 2022
All news about MODERNA, INC.
03:52aIndonesia in talks with African countries to export its homemade COVID shot
RE
03:21aIndonesia in talks with African countries to export its homemade COVID shot
RE
10/06Analysis-As China party congress looms, signals sought on easing COVID policy
RE
10/06U.S. CDC Says As Of Oct 5, 3.9 Million People Received An Updated Booster Dose For Covi..
RE
10/06COVID wave looms in Europe as booster campaign makes slow start
RE
10/05Update1 : Japan approves Pfizer's BA.5-tailored COVID-19 vaccine
AQ
10/05Covid-19 : Is The IP Truce Over?
AQ
10/05Pfizer COVID vaccine clears Japan panel for use with young children
RE
10/05Moderna asks Japan health ministry to approve BA.5-tailored vaccine
AQ
10/05EU Health Agency Grants Standard Nod to Moderna's COVID-19 Jab, Renews Conditional OK f..
MT
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2022 21 836 M - -
Net income 2022 10 884 M - -
Net cash 2022 16 503 M - -
P/E ratio 2022 4,79x
Yield 2022 -
Capitalization 48 959 M 48 959 M -
EV / Sales 2022 1,49x
EV / Sales 2023 2,85x
Nbr of Employees 2 700
Free-Float 90,5%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 125,15 $
Average target price 218,07 $
Spread / Average Target 74,2%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
James M. Mock Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-50.72%48 959
LONZA GROUP AG-33.30%38 145
IQVIA HOLDINGS INC.-33.53%34 978
SEAGEN INC.-11.85%25 135
ALNYLAM PHARMACEUTICALS, INC.18.54%24 290
CELLTRION, INC.-14.14%16 638